Modulation of peroxisome proliferator-activated receptor γ stability and transcriptional activity in adipocytes by resveratrol

被引:78
作者
Floyd, Z. Elizabeth [1 ]
Wangb, Zhong Q. [2 ]
Kilroy, Gail [1 ]
Cefalu, William T. [2 ]
机构
[1] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Ubiguitin Biol Lab, Baton Rouge, LA 70806 USA
[2] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Diabet & Nutr Lab, Baton Rouge, LA 70806 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2008年 / 57卷 / 07期
关键词
D O I
10.1016/j.metabol.2008.04.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The peroxisome proliferator-activated receptor (PPAR) gamma is essential for the formation and function of adipocytes. It is also involved in regulating insulin sensitivity and is the functional target of the thiazolidinedione class of insulin-sensitizing drugs. Whereas thiazolidinediones activate PPAR gamma and decrease PPAR gamma protein levels, genetic models indicate that decreased expression of PPAR gamma is also associated with increased insulin sensitivity. In this study, we show that resveratrol modulates PPAR gamma protein levels in 3T3-L1 adipocytes via inhibition of PPAR gamma gene expression coupled with increased ubiquitin-proteasome-dependent degradation of PPAR gamma proteins. Resveratrol-mediated decreases in PPAR gamma expression are associated with repression of PPAR gamma transcriptional activity when assayed using a panel of PPAR gamma target genes in adipocytes. Finally, we demonstrate that resveratrol inhibits insulin-dependent changes in glucose uptake and glycogen levels and decreases insulin receptor substrate 1 and glucose transporter 4 protein levels, indicating that resveratrol represses insulin sensitivity in adipocytes. These results indicate that the resveratrol-mediated effects in adipocytes involve regulation of PPAR gamma expression and transcriptional activity along with decreased responsiveness to insulin. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:S32 / S38
页数:7
相关论文
共 37 条
[21]   Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α [J].
Lagouge, Marie ;
Argmann, Carmen ;
Gerhart-Hines, Zachary ;
Meziane, Hamid ;
Lerin, Carles ;
Daussin, Frederic ;
Messadeq, Nadia ;
Milne, Jill ;
Lambert, Philip ;
Elliott, Peter ;
Geny, Bernard ;
Laakso, Markku ;
Puigserver, Pere ;
Auwerx, Johan .
CELL, 2006, 127 (06) :1109-1122
[22]   PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? [J].
Larsen, TM ;
Toubro, S ;
Astrup, A .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (02) :147-161
[23]   AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA) [J].
LEHMANN, JM ;
MOORE, LB ;
SMITHOLIVER, TA ;
WILKISON, WO ;
WILLSON, TM ;
KLIEWER, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :12953-12956
[24]   Suppression of PPAR-γ attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes [J].
Liao, Wei ;
Nguyen, M. T. Audrey ;
Yoshizaki, Takeshi ;
Favelyukis, Svetlana ;
Patsouris, David ;
Imamura, Takeshi ;
Verma, Inder M. ;
Olefsky, Jerrold M. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (01) :E219-E227
[25]   The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-γ2 isoform [J].
Medina-Gomez, G ;
Virtue, S ;
Lelliott, C ;
Boiani, R ;
Campbell, M ;
Christodoulides, C ;
Perrin, C ;
Jimenez-Linan, M ;
Blount, M ;
Dixon, J ;
Zahn, D ;
Thresher, RR ;
Aparicio, S ;
Carlton, M ;
Colledge, WH ;
Kettunen, MI ;
Seppänen-Laakso, T ;
Sethi, JK ;
O'Rahilly, S ;
Brindle, K ;
Cinti, S ;
Oresic, M ;
Burcelin, R ;
Vidal-Puig, A .
DIABETES, 2005, 54 (06) :1706-1716
[26]   Effect of heterozygous PPARγ deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding [J].
Miles, PDG ;
Barak, Y ;
Evans, RM ;
Olefsky, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (03) :E618-E626
[27]   Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency [J].
Miles, PDG ;
Barak, Y ;
He, WM ;
Evans, RM ;
Olefsky, JM .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :287-292
[28]  
Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
[29]   Altered growth in male peroxisome proliferator-activated receptor γ (PPARγ) heterozygous mice:: Involvement of PPARγ in a negative feedback regulation of growth hormone action [J].
Rieusset, J ;
Seydoux, J ;
Anghel, SI ;
Escher, P ;
Michalik, L ;
Tan, NS ;
Metzger, D ;
Chambon, P ;
Wahli, W ;
Desvergne, B .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (10) :2363-2377
[30]   The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation [J].
Schoonjans, K ;
Staels, B ;
Auwerx, J .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1302 (02) :93-109